PANAART

Pan Pharmaceuticals is a pharmaceutical company primarily focused on the manufacturing and distribution of essential medicines, with a significant presence in the antimalarial market. The company is well-known for its brand PANAART, a fixed-dose combination of artemether and lumefantrine used for the treatment of acute, uncomplicated Plasmodium falciparum malaria. Pan Pharmaceuticals operates manufacturing facilities in India and exports its products to various international markets, including Kenya, Nigeria, and other African nations. Its portfolio includes a range of dosage forms such as film-coated tablets and dispersible tablets tailored for both adult and pediatric populations. The company emphasizes compliance with international quality standards to provide cost-effective healthcare solutions in regions with high disease burdens.